Enzymatic Cellular Nanoparticles Deliver Payloads across Mucosal Barriers
Bioconjugate Chemistry · 20.08.2025 · 36 (8) · 1767-1774
DOI: 10.1021/acs.bioconjchem.5c00262 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioconjugate Chemistry, online erschienen am 17.07.2025. Verfasst von Luke J Kubiatowicz und 7 weiteren Autor:innen. Beteiligte Einrichtung: Aiiso Yufeng Li Family Department of Chemical and Nano Engineering, University of California San Diego, La Jolla, California 92093, United States. Hauptthemen laut MEDLINE: Nanoparticles, Neuraminidase, RNA, Messenger, Mucous Membrane. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Defense Threat Reduction Agency.
Abstract (Originalsprache)
Patient preferred routes of administration for therapeutics and prophylactics, such as via oral delivery and inhalation, require penetration through mucosal barriers to achieve effective bioavailability. The mucus layer is composed of glycosylated mucin proteins and serves as a robust natural defense against pathogens but also significantly impedes the delivery of medicinal agents. To overcome this barrier, we developed an innovative virus-mimicking enzymatic cellular nanoparticle designed to enhance mucopenetration. Inspired by the influenza A virus, we genetically engineered the neuraminidase protein onto the surface of mammalian cell membrane, which was subsequently used to coat mRNA-loaded lipid nanoparticle cores. This enabled the resulting nanoparticles to cleave sialic acid residues within the mucus matrix, thereby facilitating mucopenetration. In vitro studies demonstrated that these enzyme-coated cellular nanoparticles effectively traversed an artificial mucus layer, significantly enhancing mRNA delivery to underlying epithelial cells. Furthermore, in vivo experiments in a murine model showed improved lung expression of the mRNA payload after intratracheal administration. By harnessing the power of viral biomimicry, this work unveils exciting possibilities for overcoming mucosal barriers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Aiiso Yufeng Li Family Department of Chemical and Nano Engineering, University of California San Diego, La Jolla, California 92093, United States.
- Division of Host-Microbe Systems and Therapeutics, Department of Pediatrics, University of California San Diego, La Jolla, California 92093, United States.
ORCID-Profile: Luke J Kubiatowicz, Weiwei Gao, Ronnie H Fang, Liangfang Zhang
Förderung
- Defense Threat Reduction Agency
Zitieren
APA
Kubiatowicz, L. J., Pourafzal, N. N., Krishnan, N., Bao, L., Mohapatra, A., Gao, W., Fang, R. H., & Zhang, L. (2025). Enzymatic Cellular Nanoparticles Deliver Payloads across Mucosal Barriers. Bioconjugate Chemistry, 36(8), 1767-1774. https://doi.org/10.1021/acs.bioconjchem.5c00262
Vancouver
Kubiatowicz LJ, Pourafzal NN, Krishnan N, Bao L, Mohapatra A, Gao W, et al. Enzymatic Cellular Nanoparticles Deliver Payloads across Mucosal Barriers. Bioconjugate Chemistry. 2025;36(8):1767-1774. doi:10.1021/acs.bioconjchem.5c00262
BibTeX
@article{Kubiatowicz2025,
author = {Kubiatowicz, Luke J and Pourafzal, Nima N and Krishnan, Nishta and Bao, Lin and Mohapatra, Animesh and Gao, Weiwei and Fang, Ronnie H and Zhang, Liangfang},
title = {Enzymatic Cellular Nanoparticles Deliver Payloads across Mucosal Barriers},
journal = {Bioconjugate Chemistry},
year = {2025},
volume = {36},
number = {8},
pages = {1767--1774},
doi = {10.1021/acs.bioconjchem.5c00262}
}
EUVIMED